CET Ref: C-71701
CET Type: Non-interactive
Closing Date: 15 November 2019
This audio programme discusses three areas where recent research or guideline changes may improve the detection and management of ocular disease - namely Acanthamoeba keratitis, myopia therapy with low-dose atropine and screening for maculopathy due to the systemic use of chloroquine and hydroxychloroquine.
Topics: Acanthamoeba keratitis, Chloroquine, Hydroxychloroquine, Adverse side effects, Systemic drugs, Maculopathy, Low-dose atropine, Myopia, Myopia therapy, Contact lenses
Area of interest: Independent prescribing